Endovascular versus open revascularization for chronic mesenteric ischemia: a comparative study

Abstract

Percutaneous angioplasty should be preferentially offered to older patients and those unable to undergo open revascularization.

Chronic mesenteric ischaemia: 28-year experience of endovascular treatment

“…Over the past decade, more attempts at using endovascular therapy to treat symptomatic patients with total mesenteric occlusions, especially patients who are poor surgical candidates, have been undertaken. In this series, 20 patients with total arterial occlusions underwent successful CeA coeliac artery, SMA superior mesenteric artery, IMA inferior mesenteric artery Most of the literature that compares open surgery and endovascular revascularisation for CMI agrees that patients selected for endovascular treatment tend to have more comorbidities and are considered to be higher risk patients [18][19][20][21][22]24]. However, the literature also suggests that patients undergoing endovascular therapy compared with open surgical repair have less periprocedural morbidity and shorter hospital stays, and are more likely to be discharged home [1,18,21].…”

Revascularization by Percutaneous Transluminal Angioplasty for Chronic Mesenteric Ischemia: Results and One-Year Follow-up in a Single Center

“…In hospital major complications and mortality rates were 0%. The hospital length of stay rate was 3 days [2][3][4][5][6].…”

“…Other common symptoms on presentation included diarrhea 50% [7], fear of eating 21.4% [3], and nausea 14.2% [2].…”

“…Sustained improvement in symptoms is noted in 78% to 100% of patients, and 3-year patency rates of 76% to 100% have been reported. The operative mortality is moderate (0% to 13%), but post-operative complications can reach 12% to 45% [2][3][4].…”

Management of isolated spontaneous dissection of superior mesenteric artery

“…But the risk of restenosis and obstruction of side branches of the stented segments in patients often less than 60 years old should not to be underestimated [9]. Documented restenosis, thrombosis, and death related to intestinal ischemia after treatment of chronic intestinal ischemia caused by SMA stenosis was 42% after stenting and 30% after surgical revascularization at 2 years in a comparative study [24]. Among the seven cases treated by percutaneous [19].…”